Paola Cappello
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Paola Cappello has a total of 735 co-authors. Here are the top co-authors by number of shared publications:
- Francesco Novelli
Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy
76 shared publications - Emilio Hirsch
Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center “Guido Tarone”, University of Torino, Torino, Italy
32 shared publications - Mirella Giovarelli
Department of Molecular Biotechnologies and Health Sciences, University of Turin, 10126 Turin, Italy
30 shared publications Abraham V. Nguyen
17 shared publicationsChanae R. Hardamon
17 shared publications- Judith A. Varner
Moores Cancer Center, University of California, San Diego, La Jolla, CA
17 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma
(A) Agarose gel electrophoresis showing representative PCR amplicons for the indicated genotypes. The lanes correspond to different mouse samples with combinations of KrasLSL.G12D/+, HfeH67D/H67D, and Pdx1-Cre alleles. Molecular weight markers (in base pairs) are shown on the left. (B) Representative summary table of genotypes analyzed, including presence or absence of the KrasLSL.G12D/+, Pdx1-Cre, and various Hfe alleles (+/−, +/+, or −/−). (C) Representative flow cytometry histograms of CFP fluorescence intensity (CFP-A) for the assessment of cell population synchronization. Peak alignment and distribution dispersion indicate the degree of synchronization. Colored overlays denote cell cycle phases: G1 (purple), S (yellow), and G2 (green). Data are representative of independent biological replicates.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma
(A) Agarose gel electrophoresis showing representative PCR amplicons for the indicated genotypes. The lanes correspond to different mouse samples with combinations of KrasLSL.G12D/+, HfeH67D/H67D, and Pdx1-Cre alleles. Molecular weight markers (in base pairs) are shown on the left. (B) Representative summary table of genotypes analyzed, including presence or absence of the KrasLSL.G12D/+, Pdx1-Cre, and various Hfe alleles (+/−, +/+, or −/−). (C) Representative flow cytometry histograms of CFP fluorescence intensity (CFP-A) for the assessment of cell population synchronization. Peak alignment and distribution dispersion indicate the degree of synchronization. Colored overlays denote cell cycle phases: G1 (purple), S (yellow), and G2 (green). Data are representative of independent biological replicates.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma
(A) Representative immunohistochemical staining for Ki67 performed on FFPE human PDAC specimens from wild-type/non-carrier patients (WT, n = 57) and H63D carriers (n = 25) and (B) quantification of Ki67-positive area. (C) Representative Western blot analysis of HFE protein expression in FFPE PDAC tissues from WT patients and H63D carriers (including both heterozygous and homozygous cases). (D) Densitometric quantification of HFE band intensity. Values are presented as median ±SD. (E) Distribution of loss of heterozygosity (LOH) fractions at the HFE locus (chromosome 6) across PDAC samples. LOH was calculated using germline-informative heterozygous sites and matched tumor sequencing data, integrating genotype calls and allele-specific read counts. The distribution is strongly skewed toward low values, with most samples showing minimal or no allelic imbalance. Mean (dashed red line) and median (dotted green line) LOH fractions are indicated. These data indicate that LOH at the HFE locus is infrequent and not recurrent in PDAC.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma
(A) Representative immunohistochemical staining for Ki67 performed on FFPE human PDAC specimens from wild-type/non-carrier patients (WT, n = 57) and H63D carriers (n = 25) and (B) quantification of Ki67-positive area. (C) Representative Western blot analysis of HFE protein expression in FFPE PDAC tissues from WT patients and H63D carriers (including both heterozygous and homozygous cases). (D) Densitometric quantification of HFE band intensity. Values are presented as median ±SD. (E) Distribution of loss of heterozygosity (LOH) fractions at the HFE locus (chromosome 6) across PDAC samples. LOH was calculated using germline-informative heterozygous sites and matched tumor sequencing data, integrating genotype calls and allele-specific read counts. The distribution is strongly skewed toward low values, with most samples showing minimal or no allelic imbalance. Mean (dashed red line) and median (dotted green line) LOH fractions are indicated. These data indicate that LOH at the HFE locus is infrequent and not recurrent in PDAC.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma
:(A) Representative Opal multiplex immunofluorescence staining of FFPE PDAC tissues from WT (non-carrier) and H63D cases showing TWIST1 (red) and Ki67 (green), highlighting their co-localization within tumor cells. Images were acquired at 20× magnification; scale bar: 200um. (B) Representative Western blot analysis of c-MYC protein expression in FFPE PDAC tissues from HFE wild-type (WT), H63D heterozygous, and H63D homozygous carriers (upper panel). Lower panel: densitometric quantification of c-MYC band intensity normalized to GAPDH. Although c-MYC levels showed a progressive increase across genotypes, differences did not reach statistical significance (one-way ANOVA, p = 0.50). (C) Phase contrast representative images of SA β-galactosidase activity. The blue color represents the positivity to the staining. Magnification 20x. Scale bar 100 um. (D) Detection of apoptotic cells obtained by PE- Annexin V flow cytometry assay. Values are expressed as median ±SD. *p.value <0,05; **p.value <0,01 by Mann Whitney test. (E) Representative Opal multiplex immunofluorescence staining of FFPE PDAC tissues from WT (non-carrier) and H63D cases showing β2-microglobulin (red) and HFE (green), highlighting their co-localization. Images were acquired at 20× magnification; scale bar: 200um
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma
:(A) Representative Opal multiplex immunofluorescence staining of FFPE PDAC tissues from WT (non-carrier) and H63D cases showing TWIST1 (red) and Ki67 (green), highlighting their co-localization within tumor cells. Images were acquired at 20× magnification; scale bar: 200um. (B) Representative Western blot analysis of c-MYC protein expression in FFPE PDAC tissues from HFE wild-type (WT), H63D heterozygous, and H63D homozygous carriers (upper panel). Lower panel: densitometric quantification of c-MYC band intensity normalized to GAPDH. Although c-MYC levels showed a progressive increase across genotypes, differences did not reach statistical significance (one-way ANOVA, p = 0.50). (C) Phase contrast representative images of SA β-galactosidase activity. The blue color represents the positivity to the staining. Magnification 20x. Scale bar 100 um. (D) Detection of apoptotic cells obtained by PE- Annexin V flow cytometry assay. Values are expressed as median ±SD. *p.value <0,05; **p.value <0,01 by Mann Whitney test. (E) Representative Opal multiplex immunofluorescence staining of FFPE PDAC tissues from WT (non-carrier) and H63D cases showing β2-microglobulin (red) and HFE (green), highlighting their co-localization. Images were acquired at 20× magnification; scale bar: 200um
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma
(A)Relative transcript levels of EMT-TFs markers in G2-synchronized cells (murine left panel, human right panel). Experiments were performed in biological triplicates. (B) Synchronized cells were stained for Twist1/TWIST1 (in red) in both murine (upper panels) and human cells (lower panels). Magnification 20x, scale bar 100 um. (C) Representative images of wound healing scratch assay performed on G2-synchronized cells at the beginning and at the end of experiments (24 hours). Magnification 20x. Values are expressed as median ±SD. *p.value <0,05; **p.value <0,01 by Mann Whitney test.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma
(A)Relative transcript levels of EMT-TFs markers in G2-synchronized cells (murine left panel, human right panel). Experiments were performed in biological triplicates. (B) Synchronized cells were stained for Twist1/TWIST1 (in red) in both murine (upper panels) and human cells (lower panels). Magnification 20x, scale bar 100 um. (C) Representative images of wound healing scratch assay performed on G2-synchronized cells at the beginning and at the end of experiments (24 hours). Magnification 20x. Values are expressed as median ±SD. *p.value <0,05; **p.value <0,01 by Mann Whitney test.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma
(A) qRT-PCR screening of three independent HFE-targeting siRNAs (siRNA1–3), a pooled siRNA mixture, scramble control, and untreated control in MiaPaCa2 cells (WT for HFE mutation). Relative HFE transcript levels are shown as ΔCt values normalized to 18S.(B) qRT-PCR screening of the same siRNA panel in PANC-1 cells (H63D carriers). (C) Representative Western blot showing HFE and TWIST1 protein expression in MiaPaCa2, A8184, PANC-1, PANC-1 + HFE siRNA, and PANC-1 + scramble. GAPDH was used as loading control. (D) Densitometric quantification of HFE protein levels normalized to GAPDH. (E) Relative mRNA expression of EMT-transcription factor genes (CDH1, CDH2, TWIST1, ZEB1, ZEB2) in wild-type PDAC cell lines (A8184 and MiaPaCa2) following HFE silencing or control treatment. (F) Relative mRNA expression of cell-cycle regulators (CCNC, CCND1, CCNE, CCNA, CCNB) in A8184 and MiaPaCa2 cells after HFE knockdown or control treatment. (G) Densitometric quantification of TWIST1 protein levels normalized to GAPDH. (H) Cell-cycle phase distribution of PANC-1 cells (homozygous H63D) under control conditions or following HFE siRNA treatment. (I) Relative mRNA expression of EMT-related genes (CDH1, SLUG, TWIST, ZEB2, SNAIL) in synchronized PANC-1 cells analyzed in G1 and G2 phases under untreated, scramble, or HFE-silenced conditions. Values are presented as median ±SD. *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 6 from The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma
(A) qRT-PCR screening of three independent HFE-targeting siRNAs (siRNA1–3), a pooled siRNA mixture, scramble control, and untreated control in MiaPaCa2 cells (WT for HFE mutation). Relative HFE transcript levels are shown as ΔCt values normalized to 18S.(B) qRT-PCR screening of the same siRNA panel in PANC-1 cells (H63D carriers). (C) Representative Western blot showing HFE and TWIST1 protein expression in MiaPaCa2, A8184, PANC-1, PANC-1 + HFE siRNA, and PANC-1 + scramble. GAPDH was used as loading control. (D) Densitometric quantification of HFE protein levels normalized to GAPDH. (E) Relative mRNA expression of EMT-transcription factor genes (CDH1, CDH2, TWIST1, ZEB1, ZEB2) in wild-type PDAC cell lines (A8184 and MiaPaCa2) following HFE silencing or control treatment. (F) Relative mRNA expression of cell-cycle regulators (CCNC, CCND1, CCNE, CCNA, CCNB) in A8184 and MiaPaCa2 cells after HFE knockdown or control treatment. (G) Densitometric quantification of TWIST1 protein levels normalized to GAPDH. (H) Cell-cycle phase distribution of PANC-1 cells (homozygous H63D) under control conditions or following HFE siRNA treatment. (I) Relative mRNA expression of EMT-related genes (CDH1, SLUG, TWIST, ZEB2, SNAIL) in synchronized PANC-1 cells analyzed in G1 and G2 phases under untreated, scramble, or HFE-silenced conditions. Values are presented as median ±SD. *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma
Representative images of wound-healing (scratch) assays performed on G1-and G2-synchronized PANC-1 cells, including HFE-silenced, captured at baseline and after 24 hours. Magnification 20×.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma
Representative images of wound-healing (scratch) assays performed on G1-and G2-synchronized PANC-1 cells, including HFE-silenced, captured at baseline and after 24 hours. Magnification 20×.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 8 from The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma
(A) H&E sections of Visium-analyzed tumor biopsies, with circles indicating tumoral areas, including the tumor-stroma interface, as marked by the pathologist for WT, non-carriers (top) and H63D (bottom) samples. (B) H&E slices with selected spots mapped and color-coded according to tissue morphology. (C) GSEA enrichment plots showing the running scores for EMT and the G2M phase checkpoint.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 8 from The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma
(A) H&E sections of Visium-analyzed tumor biopsies, with circles indicating tumoral areas, including the tumor-stroma interface, as marked by the pathologist for WT, non-carriers (top) and H63D (bottom) samples. (B) H&E slices with selected spots mapped and color-coded according to tissue morphology. (C) GSEA enrichment plots showing the running scores for EMT and the G2M phase checkpoint.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary figure 3 from The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma
Representative hematoxylin and eosin (H&E) staining of murine pancreatic tissue from KC WT and h67d mice at different ages. Red boxes indicate selected regions of interest, labeled as 1, 2, and 3.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary figure 3 from The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma
Representative hematoxylin and eosin (H&E) staining of murine pancreatic tissue from KC WT and h67d mice at different ages. Red boxes indicate selected regions of interest, labeled as 1, 2, and 3.
- Open Access
- 12 September 2026
- Published by Elsevier in Digestive and Liver Disease
- Vol. 58 (11) , 1377-1388
AISP position statement: Standardising biological sample collection and handling for advanced diagnostics and multi-omic analyses in pancreatic cancer
- 12 September 2026
- Published by Elsevier in Digestive and Liver Disease
- Vol. 58 (11) , 1377-1388
Open AccessAISP position statement: Standardising biological sample collection and handling for advanced diagnostics and multi-omic analyses in pancreatic cancer